Related Experiment Video
Updated: May 11, 2026

A Flexible Low Cost Hydroponic System for Assessing Plant Responses to Small Molecules in Sterile Conditions
Published on: August 25, 2018
Survival, clinical, and genetic findings in paediatric cardiomyopathy: a five-year prospective study from Brazil
Ana Flávia M Torbey1,2, Raquel G T Couto3, Aurea Lucia A A G de Souza1,3
1Fluminense Federal University, Niterói, Rio de Janeiro, Brazil.
Insights
This study reveals high genetic positivity in Brazilian pediatric cardiomyopathy patients, especially with systemic involvement. Key clinical factors predict mortality, aiding risk stratification and care for these complex heart conditions.
Area of Science:
- Cardiology
- Genetics
- Pediatrics
Background:
- Limited prospective cohort studies exist on pediatric cardiomyopathies in Brazil, particularly integrating clinical and genetic data.
- This study addresses the gap by examining a cohort in a Brazilian metropolitan region.
Purpose of the Study:
- To characterize the clinical and genetic profiles of pediatric cardiomyopathy patients in Brazil.
- To identify predictors of mortality in this population to improve patient management.
Main Methods:
- A prospective observational study was conducted on pediatric patients diagnosed with cardiomyopathies.
- Clinical data, genetic findings, and survival outcomes were collected and analyzed.
- Kaplan-Meier curves were used to assess survival rates and identify significant predictors.
Main Results:
- The study included 45 pediatric patients, with a male predominance and a mean age of 6.5 years at diagnosis. Dilated and hypertrophic cardiomyopathies were most prevalent.
- Genetic testing revealed a 60% positivity rate, significantly higher in cases with multi-organ/system involvement (77.7%).
- Mortality was 11.1%, with significantly lower survival associated with reduced ejection fraction (<30%), advanced functional class (III/IV), heart failure, extensive medication use, elevated NT-proBNP (>1000 pg/mL), and heart transplant indication.
Conclusions:
- This research provides crucial new data on pediatric cardiomyopathies in Brazil, emphasizing a high rate of genetic diagnoses.
- The findings underscore the importance of genetic testing, especially in patients with systemic manifestations.
- Identified clinical predictors of mortality are vital for refining risk stratification and guiding clinical care strategies.
Background:
Although global knowledge on paediatric cardiomyopathies has advanced, prospective cohort studies from Brazil, particularly those integrating clinical and genetic data, remain limited.
Objective:
To describe the clinical and genetic characteristics of paediatric cardiomyopathy patients and identify mortality predictors in a metropolitan region of Brazil.
Methods:
Prospective observational study of paediatric patients with cardiomyopathies. Clinical data, genetic findings, and survival were analysed using Kaplan-Meier curves.
Results:
A total of 45 cases, male predominance (55.6%), and mean age at diagnosis of 6.5 years. Dilated and hypertrophic cardiomyopathy were the most common (33.3%). The main reason for diagnosis was the investigation of cardiovascular symptoms (60.9%). Genetic investigation occurred in 66.6%, a positivity rate of 60%. Multi-organ/system involvement was significantly associated with a positive genetic result (77.7%, p = 0.017). Mortality was 11.1%; survival was significantly lower in the following conditions: ejection fraction < 30% (p < 0.0001), functional class III/IV (p < 0.0001), heart failure (p = 0.0091), use of three or more cardiovascular medications (p < 0.001), N-Terminal Pro-B-Type natriuretic peptide >1000pg/mL (p = 0.004), and heart transplant indication (p < 0.001).
Conclusion:
These findings provide novel data in Brazil, highlight a high rate of positive genetic test, particularly among patients with systemic involvement and identify key clinical predictors of mortality to guide risk stratification and care.
More Related Videos
Related Concept Videos
Pathophysiology of Cardiac Performance
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

